Skip to main content
  • 2495 Accesses

Abstract

Male breast cancer (MBC) is a relatively rare disease, accounting for <1% of all breast cancers in the western world and 0.1% of cancer deaths in men . The causes are still poorly understood and the low incidence of MBC means that studies are small and underpowered. The treatment of MBC is based on large trials in postmenopausal women. The outlook for men is the same as women stage for stage, but overall the prognosis tends to be poorer. This is usually due to a delay in presentation – despite increasing awareness of MBC, there remains an average delay from the onset of symptoms to diagnosis of 6–10 months, with little improvement in survival over the last 25 years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Nat Cancer Inst. 2003;95:1276–99.

    Article  PubMed  Google Scholar 

  2. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.

    Article  PubMed  CAS  Google Scholar 

  3. O’Malley CD, Prehn AW, Shema SJ, et al. Racial/ethnic differences in survival rates in a population based series of men with breast cancer. Cancer. 2002;94:2836–42.

    Article  PubMed  Google Scholar 

  4. Sheik O. Male breast cancer: factors influencing prognosis. Br J Cancer. 1975;30:13–35.

    Google Scholar 

  5. Hodgson NC, Button JH, Franceschi D, et al. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;2010(8):751–5.

    Article  Google Scholar 

  6. Mabuchi K, Bross DS, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst. 1985;74:371–5.

    PubMed  CAS  Google Scholar 

  7. Ojara EA. Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J. 1978;55:489–91.

    PubMed  CAS  Google Scholar 

  8. Bhagwandin S. Carcinoma of the male breast in Zambia. East Afr Med J. 1972;49:176–9.

    Google Scholar 

  9. Waterhouse J, Muir C, Correa P, et al. Cancer incidence in five continents, vol 3. IARC Sci Publ 1976;(15):1–583.

    Google Scholar 

  10. Anderson WF, Althius MD, Brinton LA, et al. Is male breast cancer similar or different from female breast cancer? Br Cancer Res Treat. 2004;83:77–86.

    Article  Google Scholar 

  11. Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4(1):R2.

    Article  PubMed  CAS  Google Scholar 

  12. Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 ­mutations in a male breast cancer population. Am J Hum Genet. 1997;60:313–9.

    PubMed  CAS  Google Scholar 

  13. Fackenthal JD, Marsh DJ, Richardson AL, et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet. 2001;38:159–64.

    Article  PubMed  CAS  Google Scholar 

  14. Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter’s syndrome. J Med Genet. 1971;8:460–1.

    Article  PubMed  CAS  Google Scholar 

  15. Price WH, Clayton JF, Wilson J, Collyer S, De Mey R. Causes of death in X chromatin positive males (Klinefelter’s syndrome). J Epidemiol Community Health. 1985;39:330–6.

    Article  PubMed  CAS  Google Scholar 

  16. McLaughlin JK, Malker BR, Blot WJ, et al. Occupational risks for male breast cancer in Sweden. Br J Indust Med. 1988;4:275–6.

    Google Scholar 

  17. Hansen J. Elevated risk for male breast cancer after exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000;37:349–52.

    Article  PubMed  CAS  Google Scholar 

  18. Loomis DP. Cancer of breast among men in electrical occupations. Lancet. 1992;339:1482–3.

    Article  PubMed  CAS  Google Scholar 

  19. Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C, et al. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer. 1990;45:661–5.

    Article  PubMed  CAS  Google Scholar 

  20. Olsson H, Ranstam J. Head trauma and exposure to Prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst. 1988;80:679–83.

    Article  PubMed  CAS  Google Scholar 

  21. Sasco AJ, Lowenfels AB, Pasker de Jong P. Epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:539–49.

    Article  Google Scholar 

  22. Ron E, Ikeda T, Preston DL, et al. Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst. 2005;97:603–5.

    Article  PubMed  Google Scholar 

  23. McClure JA, Higgins CC. Bilateral carcinoma of male breast after estrogen therapy. JAMA. 1951;146:7–9.

    Article  CAS  Google Scholar 

  24. Symmers WSC. Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sexual characteristics. Br Med J. 1968;2:83–5.

    Article  PubMed  CAS  Google Scholar 

  25. Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with ­hormonal implications. Am J Epidemiol. 1992;135:734–48.

    PubMed  CAS  Google Scholar 

  26. Johnson KC, Pan S, Mao Y. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev. 2002;2010:253–63.

    Article  Google Scholar 

  27. Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control. 1998;9:269–76.

    Article  PubMed  CAS  Google Scholar 

  28. Guenel P, Cyr D, Sabroe S, et al. Alcohol drinking may increase the risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control. 2004;15:571–80.

    Article  PubMed  Google Scholar 

  29. Volm MD, Talamonti MS, Thangavelu M, et al. Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol. 1997;64:74–8.

    Article  PubMed  CAS  Google Scholar 

  30. Ribeiro GG, Swindell R, Harris M, et al. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast. 1996;5:141–6.

    Article  Google Scholar 

  31. van Geel AN, van Slooten EA, Mavrunac M, et al. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724–7.

    Article  PubMed  Google Scholar 

  32. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 cases who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629–39.

    Article  PubMed  CAS  Google Scholar 

  33. Scheike O. Male breast cancer. Acta Pathol Microbiol Scand. 1975;S251:3–35.

    Google Scholar 

  34. Ramantanis G, Besbeas S, Garas JG, et al. Breast cancer in the male: a report of 138 cases. World J Surg. 1980;4:621–4.

    Article  PubMed  CAS  Google Scholar 

  35. Stewart RAL, Howlett DC, Hearn FJ. Pictorial review: the imaging features of male breast disease. Clin Radiol. 1997;52:739–44.

    Article  PubMed  CAS  Google Scholar 

  36. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males. Cancer. 1998;83:498–509.

    Article  PubMed  CAS  Google Scholar 

  37. Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143–51.

    Article  PubMed  CAS  Google Scholar 

  38. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population based study. Cancer. 2004;101:51–7.

    Article  PubMed  Google Scholar 

  39. Michaels BM, Nunn CR, Roses DF. Lobular carcinoma of the male breast. Surgery. 1994;20105:402–5.

    Google Scholar 

  40. Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:2139–49.

    Article  Google Scholar 

  41. Meijer-van Gelder ME, Look MP, Bolt-de Vries J, et al. Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat. 2001;68:249–60.

    Article  PubMed  CAS  Google Scholar 

  42. Bloom KJ, Govil H, Gattuso P, et al. Status of HER-2 in male and female breast carcinomas. Am J Surg. 2001;82:389–92.

    Article  Google Scholar 

  43. Scott-Connor CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–80.

    Article  Google Scholar 

  44. France L, Michie S, Barrett-Lee P, et al. Male breast cancer: a qualitative study of male breast cancer. Breast. 2000;9:342–8.

    Article  Google Scholar 

  45. Spear SL, Bowen DG. Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg. 1998;102:1615–7.

    Article  PubMed  CAS  Google Scholar 

  46. Albo D, Ames FC, Hunt KK, et al. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003;77:9–14.

    Article  PubMed  CAS  Google Scholar 

  47. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer. Br J Cancer. 1992;65:252–4.

    Article  PubMed  CAS  Google Scholar 

  48. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604.

    Article  PubMed  Google Scholar 

  49. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960–4.

    Article  PubMed  CAS  Google Scholar 

  50. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13 year review of 89 patients. J Clin Oncol. 1984;2:903–9.

    PubMed  CAS  Google Scholar 

  51. Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast cancer. Cancer. 2005;104:235–64.

    Article  Google Scholar 

  52. Yildirim E, Berberoglu U. Male breast cancer: a 22 year experience. Eur J Surg Oncol. 1998;24:548–52.

    Article  PubMed  CAS  Google Scholar 

  53. Jaiyesimi IA, Buzdar AU, Sahin AA, et al. Carcinoma of the male breast. Ann Internal Med. 1992;20107:771–7.

    Google Scholar 

  54. Irvine T, Fentiman S. Male breast cancer. CML Breast Cancer. 2007;19(1):1–6.

    Google Scholar 

  55. Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer. 1993;71(1):154–61.

    Article  PubMed  CAS  Google Scholar 

  56. NCCN clinical practice guidelins in Oncology ™ genetic/familial high-risk assessment: breast and ovarian. V.I. 2008. (http://www.nccn.org/professionals/physician_gls/PDF/­genetics_screening.pdf).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian S. Fentiman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer New York

About this chapter

Cite this chapter

Irvine, T., Fentiman, I.S. (2010). Male Breast Cancer. In: Dirbas, F., Scott-Conner, C. (eds) Breast Surgical Techniques and Interdisciplinary Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6076-4_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6076-4_46

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6075-7

  • Online ISBN: 978-1-4419-6076-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics